Breast cancer research and treatment

Keyphrases

Publications

volume 207, number 1, 2024

Daniela Nasif, Sergio Laurito, Sebastian Real, María Teresita Branham
Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights into methylation patterns and chromatin accessibility dynamics. Breast cancer research and treatment 207 (1) (2024)
Evelyn Klein, Marion Kiechle, Adriana Josipovic, Sophie-Isabelle Anders, Aurelia Noske, Carolin Mogler, Alexander Hapfelmeier, Johannes Ettl
Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer. Breast cancer research and treatment 207 (1) (2024)
Sarah A Anderson, Brooke B Bartow, Shuko Harada, Gene P Siegal, Shi Wei, Valeria L Dal Zotto, Xiao Huang
p53 protein expression patterns associated with TP53 mutations in breast carcinoma. Breast cancer research and treatment 207 (1) (2024)
Emma Rewcastle, Ivar Skaland, Einar Gudlaugsson, Silja Kavlie Fykse, Jan P A Baak, Emilius A M Janssen
The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer. Breast cancer research and treatment 207 (1) (2024)
Xiao Shi, Yuan Sheng, Haoran Fei, Bangbang Wei, Zhenyu Zhang, Xinyu Xia, Changfei Mao, Xinxin Si
Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer. Breast cancer research and treatment 207 (1) (2024)

volume 207, number 2, 2024

Jincong Q Freeman, Jori B Sheade, Fangyuan Zhao, Olufunmilayo I Olopade, Dezheng Huo, Rita Nanda
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer. Breast cancer research and treatment 207 (2) (2024)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang, Lynne I Wagner, David Cella, Neal J Meropol, R Katherine Alpaugh, Thomas J Saphner, Robert E Swaney, Karen L Hoelzer, William J Gradishar, Vandana G Abramson, P Kothai Sundaram, Shamim Z Jilani, Edith A Perez, Nancy U Lin, Mohammad Jahanzeb, Antonio C Wolff, George W Sledge, Sonya A Reid
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105). Breast cancer research and treatment 207 (2) (2024)
Nerina C van der Merwe, Ines Buccimazza, Bianca Rossouw, Monica Araujo, Kholiwe S Ntaita, Mardelle Schoeman, Karin Vorster, Kgabo Napo, Maritha J Kotze, Jaco Oosthuizen
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Elisabete Gonçalves, Filipa Fontes, Jéssica Rocha Rodrigues, Rita Calisto, Maria José Bento, Nuno Lunet, Samantha Morais
The contribution of second primary cancers to the mortality of patients with a first primary breast cancer. Breast cancer research and treatment 207 (2) (2024)
Lara Schwieger, Lauren M Postlewait, Yi Liu, Stephanie Jou, Sha Yi, Limin Peng, Xiaoxian Li
Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival. Breast cancer research and treatment 207 (2) (2024)
Katherine Marie Cole, Sharon McGee, Mark Clemons, Michelle Liu, Fiona MacDonald, Lisa Vandermeer, Terry L Ng, Gregory Pond, Khaled El Emam
Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study. Breast cancer research and treatment 207 (2) (2024)
Katherine Marie Cole, Sharon McGee, Mark Clemons, Michelle Liu, Fiona MacDonald, Lisa Vandermeer, Terry L Ng, Gregory Pond, Khaled El Emam
Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study. Breast cancer research and treatment 207 (2) (2024)
Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment 207 (2) (2024)
Wenning Shi, Cong Xu, Ping Lei, Xiaoli Sun, Mengju Song, Yacong Guo, Wenxuan Song, Yizheng Li, Liting Yu, Hui Zhang, Hongmei Wang, Dao-Lai Zhang
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer. Breast cancer research and treatment 207 (2) (2024)
Nerina C van der Merwe, Ines Buccimazza, Bianca Rossouw, Monica Araujo, Kholiwe S Ntaita, Mardelle Schoeman, Karin Vorster, Kgabo Napo, Maritha J Kotze, Jaco Oosthuizen
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Michael Cronin, Aoife Lowery, Veronica McInerney, William Wijns, Michael Kerin, Maccon Keane, Silvie Blazkova, Dina Neiuroukh, Michael Martin, Juan Carlos Parodi
Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Luca Boldrini, Loredana Dinapoli, Edda Boccia, Morena Caliandro, Sarah Pia Colangione, Chiara Elia, Veronica Pollutri, Gaia Sartori, Fabiana Gregucci, Elisa Marconi, Stefania Manfrida, Valeria Masiello, Daniela Pia Rosaria Chieffo, Fabio Marazzi, Alba Fiorentino, Maria Antonietta Gambacorta
Coping with modesty during radiotherapy for breast cancer: a multicentric study. Breast cancer research and treatment 207 (2) (2024)
Christian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, Athanasios Argyriadis, Volker Möbus, Christine Solbach, Peter Baier, Dagmar Giesecke, Sven Ackermann, Elke Schulmeyer, Boris Gabriel, Dietrich Mosch, Stephanie Buchen, Eckart Krapfl, Ursula Hurst, Mario Vescia, Hans Tesch, Marc Thill
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer. Breast cancer research and treatment 207 (2) (2024)
Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment 207 (2) (2024)
Yanfeng Li, Wengxing Long, Hongda Zhou, Tao Tan, Hui Xie
Revolutionizing breast cancer Ki-67 diagnosis: ultrasound radiomics and fully connected neural networks (FCNN) combination method. Breast cancer research and treatment 207 (2) (2024)
Elisabete Gonçalves, Filipa Fontes, Jéssica Rocha Rodrigues, Rita Calisto, Maria José Bento, Nuno Lunet, Samantha Morais
The contribution of second primary cancers to the mortality of patients with a first primary breast cancer. Breast cancer research and treatment 207 (2) (2024)
Nerina C van der Merwe, Ines Buccimazza, Bianca Rossouw, Monica Araujo, Kholiwe S Ntaita, Mardelle Schoeman, Karin Vorster, Kgabo Napo, Maritha J Kotze, Jaco Oosthuizen
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Elisabete Gonçalves, Filipa Fontes, Jéssica Rocha Rodrigues, Rita Calisto, Maria José Bento, Nuno Lunet, Samantha Morais
The contribution of second primary cancers to the mortality of patients with a first primary breast cancer. Breast cancer research and treatment 207 (2) (2024)
Kristen D Brantley, Rulla M Tamimi
The association between infectious agents and breast cancer: a review of the epidemiologic evidence. Breast cancer research and treatment 207 (2) (2024)
Yanfeng Li, Wengxing Long, Hongda Zhou, Tao Tan, Hui Xie
Revolutionizing breast cancer Ki-67 diagnosis: ultrasound radiomics and fully connected neural networks (FCNN) combination method. Breast cancer research and treatment 207 (2) (2024)
Christian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, Athanasios Argyriadis, Volker Möbus, Christine Solbach, Peter Baier, Dagmar Giesecke, Sven Ackermann, Elke Schulmeyer, Boris Gabriel, Dietrich Mosch, Stephanie Buchen, Eckart Krapfl, Ursula Hurst, Mario Vescia, Hans Tesch, Marc Thill
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer. Breast cancer research and treatment 207 (2) (2024)
Ayaka Isogai, Kazuki Nozawa, Akira Nakakami, Rie Komaki, Yuri Ozaki, Yuka Endo, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study. Breast cancer research and treatment 207 (2) (2024)
Michael Cronin, Aoife Lowery, Veronica McInerney, William Wijns, Michael Kerin, Maccon Keane, Silvie Blazkova, Dina Neiuroukh, Michael Martin, Juan Carlos Parodi
Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Katherine Marie Cole, Sharon McGee, Mark Clemons, Michelle Liu, Fiona MacDonald, Lisa Vandermeer, Terry L Ng, Gregory Pond, Khaled El Emam
Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study. Breast cancer research and treatment 207 (2) (2024)
Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment 207 (2) (2024)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang, Lynne I Wagner, David Cella, Neal J Meropol, R Katherine Alpaugh, Thomas J Saphner, Robert E Swaney, Karen L Hoelzer, William J Gradishar, Vandana G Abramson, P Kothai Sundaram, Shamim Z Jilani, Edith A Perez, Nancy U Lin, Mohammad Jahanzeb, Antonio C Wolff, George W Sledge, Sonya A Reid
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105). Breast cancer research and treatment 207 (2) (2024)
Jincong Q Freeman, Jori B Sheade, Fangyuan Zhao, Olufunmilayo I Olopade, Dezheng Huo, Rita Nanda
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer. Breast cancer research and treatment 207 (2) (2024)
Ashish Gupta, Arya Mariam Roy, Kush Gupta, Kristopher Attwood, Asha Gandhi, Stephen Edge, Kazuaki Takabe, Elizabeth Repasky, Song Yao, Shipra Gandhi
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study. Breast cancer research and treatment 207 (2) (2024)
Xiaojuan Ran, Anling Hu, Yi Kuang, Chunlin Wang, Wuling Liu, Xiao Xiao, Eldad Zacksenhaus, Xiangdi Yu, Yaacov Ben-David
UM171 suppresses breast cancer progression by inducing KLF2. Breast cancer research and treatment 207 (2) (2024)
Xiaojuan Ran, Anling Hu, Yi Kuang, Chunlin Wang, Wuling Liu, Xiao Xiao, Eldad Zacksenhaus, Xiangdi Yu, Yaacov Ben-David
UM171 suppresses breast cancer progression by inducing KLF2. Breast cancer research and treatment 207 (2) (2024)
Ashish Gupta, Arya Mariam Roy, Kush Gupta, Kristopher Attwood, Asha Gandhi, Stephen Edge, Kazuaki Takabe, Elizabeth Repasky, Song Yao, Shipra Gandhi
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study. Breast cancer research and treatment 207 (2) (2024)
Nerina C van der Merwe, Ines Buccimazza, Bianca Rossouw, Monica Araujo, Kholiwe S Ntaita, Mardelle Schoeman, Karin Vorster, Kgabo Napo, Maritha J Kotze, Jaco Oosthuizen
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Ji Won Woo, Eun Kyung Han, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer. Breast cancer research and treatment 207 (2) (2024)
Elisabete Gonçalves, Filipa Fontes, Jéssica Rocha Rodrigues, Rita Calisto, Maria José Bento, Nuno Lunet, Samantha Morais
The contribution of second primary cancers to the mortality of patients with a first primary breast cancer. Breast cancer research and treatment 207 (2) (2024)
Christian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, Athanasios Argyriadis, Volker Möbus, Christine Solbach, Peter Baier, Dagmar Giesecke, Sven Ackermann, Elke Schulmeyer, Boris Gabriel, Dietrich Mosch, Stephanie Buchen, Eckart Krapfl, Ursula Hurst, Mario Vescia, Hans Tesch, Marc Thill
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer. Breast cancer research and treatment 207 (2) (2024)
Xiaojuan Ran, Anling Hu, Yi Kuang, Chunlin Wang, Wuling Liu, Xiao Xiao, Eldad Zacksenhaus, Xiangdi Yu, Yaacov Ben-David
UM171 suppresses breast cancer progression by inducing KLF2. Breast cancer research and treatment 207 (2) (2024)
Ashish Gupta, Arya Mariam Roy, Kush Gupta, Kristopher Attwood, Asha Gandhi, Stephen Edge, Kazuaki Takabe, Elizabeth Repasky, Song Yao, Shipra Gandhi
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study. Breast cancer research and treatment 207 (2) (2024)
Michael Cronin, Aoife Lowery, Veronica McInerney, William Wijns, Michael Kerin, Maccon Keane, Silvie Blazkova, Dina Neiuroukh, Michael Martin, Juan Carlos Parodi
Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients. Breast cancer research and treatment 207 (2) (2024)
Ji Won Woo, Eun Kyung Han, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer. Breast cancer research and treatment 207 (2) (2024)
Jincong Q Freeman, Jori B Sheade, Fangyuan Zhao, Olufunmilayo I Olopade, Dezheng Huo, Rita Nanda
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer. Breast cancer research and treatment 207 (2) (2024)
Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, Carlos L Arteaga, Ximing J Yang, Lynne I Wagner, David Cella, Neal J Meropol, R Katherine Alpaugh, Thomas J Saphner, Robert E Swaney, Karen L Hoelzer, William J Gradishar, Vandana G Abramson, P Kothai Sundaram, Shamim Z Jilani, Edith A Perez, Nancy U Lin, Mohammad Jahanzeb, Antonio C Wolff, George W Sledge, Sonya A Reid
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105). Breast cancer research and treatment 207 (2) (2024)
Tian Fang, Shiheng Hu, Xinhao Song, Junqi Wang, Runan Zuo, Shifeng Yun, Shanxiang Jiang, Dawei Guo
Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways. Breast cancer research and treatment 207 (2) (2024)
Ashish Gupta, Arya Mariam Roy, Kush Gupta, Kristopher Attwood, Asha Gandhi, Stephen Edge, Kazuaki Takabe, Elizabeth Repasky, Song Yao, Shipra Gandhi
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study. Breast cancer research and treatment 207 (2) (2024)
Ji Won Woo, Eun Kyung Han, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer. Breast cancer research and treatment 207 (2) (2024)
Miki Yamada, Hiromitsu Jinno, Saki Naruse, Yuka Isono, Yuka Maeda, Ayana Sato, Akiko Matsumoto, Tatsuhiko Ikeda, Masahiro Sugimoto
Predictive analysis of breast cancer response to neoadjuvant chemotherapy through plasma metabolomics. Breast cancer research and treatment 207 (2) (2024)